Get notified when HCWB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Will Not Be Exercisable and Therefore Have No Value (new) — The warrants are contingent on shareholder approval, and if not obtained, they become worthless.
HCW Biologics prices $1.5M unit offering at $0.6055 per unit; warrants contingent on shareholder approval
Filed February 19, 2026 · ~1 min read
Key Changes
-
high
HCW Biologics is offering 2,477,292 units at $0.6055 each, each unit consisting of one share and one warrant, for gross proceeds of about $1.5 million.
The Offering verify on EDGAR → -
high
The warrants are exercisable only after shareholder approval, at $0.6055 per share, expiring five years after approval; if approval is not obtained, the warrants have no value.
The Offering verify on EDGAR → -
medium
The offering is primary, so all proceeds go to the company.
The Offering verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CBRL 10-K) is open in full — no account needed.
Partner
Trade HCWB commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify